greening the health sector - pharmaceuticals and climate change
DESCRIPTION
TRANSCRIPT
Greening the Health Sector
Dr. Christoph HamelmannRegional Practice Leader HIV, Health and Development
UNDP Europe and Central Asia
CIS Pharmaceutical ForumMoscow, Russia, 5 January 2013
Pharmaceuticals and Climate Changec
c c
Likely Temperature Increaseby GHG Emission Pathways
Energy Intensity (Energy consumption per unit GDP 2011, ENERDATA)
Countries Energy Intensity World Major Country Ranking (highest 4)
Uzbekistan 0.633 1Ukraine 0.436 2Kazakhstan 0.399 3Russia 0.346 4
Countries Unconditional Pledge Conditional Pledge Current GHG Emissions (MtCO2e 2010)
Armenia - Submitted policy actions 11
Azerbaijan - - 50
Belarus Reduction 8 % below 1990 level by 2020 - 150
Kazakhstan Reduction 15 % below 1990 level by 2020 - 318
Kyrgyzstan - - ?
Moldova Reduction 25 % below 1990 level by 2020 - 11
Russia Reduction 15 % below 1990 level by 2020 Reduction 25 % below 1990 level by 2020
2510
Tajikistan - Submitted policy actions 15
Uzbekistan - - 174
Turkmenistan - - 87
Ukraine Reduction 20 % below 1990 level by 2020 - 397
GHG Emission Reduction PledgesCIS Countries
Health Sector in the ECIS Region
• Accounts for 7.5 % of GDP• Technology intensive with significant
consumption of resources, associated with environmental pollution and degradation
• Accounts for an estimated 4.2 % of greenhouse gases (GHG) in the ECIS region
• Up to 25 % of these GHG can be reduced within short-term, more through long-term measures
• Reductions have also direct positive impact on life-years saved
Ministerial European Environment and Health Task Force Meeting, Bled / Slovenia 2011
NHS Carbon Footprint Breakdown 2010
+ others
European Ministerial Environment & Health Task Force
Fifth Ministerial Conferenceon Environment and Health
Parma 2010
53 member states, including all CIS countries
Sector Guidance on Carbon Foot-Printing• Cross-sectoral partnership• Standardized quantification of
the GHG inventory of pharmaceutical products certified by international GHG protocol
• Identification of hot spots throughout the product life cycle
• Focus on minimizing carbon footprint for producers, buyers and users of pharmaceutical products http://www.sdu.nhs.uk/pharma-md
Marginal Abatement Costs
Gaining Efficiencies – Reducing GHG EmissionsLessons Learnt From Pharma-Industry
Stay competitive!
ESA
Economic Commission for EuropeReport Regional Preparatory Meeting
Public procurement47. Sustainable public procurement was supported as a first critical step to further the green economy at the national as well as the sub-national level. Concrete progress was proposed in the form of sustainable public procurement targets that could be met by an increasing number of countries over the years.
Leadership and Innovations
